Stemcentrx's Series C Round

Stemcentrx raised a round of funding on March 16, 2011. Investors include Artis Ventures.

Stemcentrx is developing novel cancer therapies and diagnostics. Stemcentrx is looking to treat cancers by killing cancer stem cells, or cells thought to initiate tumors. These cells are believed to r…

Articles about Stemcentrx's Series C Round: